As indicated in Figure 1, the SOD activity of MS subjects was significantly reduced compared with that of non-MS subjects (P = 0.001), whereas age-adjusted LTL, age-adjusted mtDNAcn, 8-OHdG, and GR were comparable between individuals with and without MS. This evidence concerns the gene SOD1 and myeloid sarcoma.